|
Rhythm Pharmaceuticals inc (NASDAQ: RYTM) |
|
Rhythm Pharmaceuticals inc
RYTM's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Rhythm Pharmaceuticals Inc growth rates, revenue grew
by 72.99 % in III. Quarter 2024 from the same quarter a year ago.
Ranking at No. 56
Major Pharmaceutical Preparations industry recorded
growth of revenues by 9.75 %
Rhythm Pharmaceuticals Inc net loss decreased from $-47 millions, to $-45 millions in III. Quarter 2024,
• More on RYTM's Growth
|
|
Rhythm Pharmaceuticals Inc realized a net loss in trailing twelve months.
Rhythm Pharmaceuticals Inc realized cash reduction of $ -1.04 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 32.31.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.4.
• More on RYTM's Valuation
|
|
|
|
|
Rhythm Pharmaceuticals Inc realized net loss in trailing twelve months.
Rhythm Pharmaceuticals Inc realized cash outflow of $ -1.04per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 32.31.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.4.
Rhythm Pharmaceuticals Inc Price to Book Ratio is at 319.17 higher than Industry Avg. of 82.29, and higher than S&P 500 Avg. of 0.02
• More on RYTM's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com